
Journal Menu
► ▼ Journal Menu-
- JPM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
27 September 2024
MDPI’s 2023 Travel Awards—Winners Announced

MDPI journals frequently grant travel awards to empower junior researchers to showcase their latest research at academic conferences, thereby amplifying their impact within their research fields.
We extend our heartfelt congratulations to the 103 recipients of MDPI's 2023 Travel Awards from different countries and territories for their exceptional presentations. These outstanding individuals were selected by the journal editors based on the strength of their research proposals and the anticipated impact of their presentations at academic conferences. We commend their exceptional contributions and wish them continued success in their academic endeavors.
MDPI will continue to provide support and recognition to the academic community. To learn more about the list of awardees, please visit the following pages:
- Biology and Life Sciences;
- Chemistry and Materials Sciences;
- Engineering;
- Environmental and Earth Sciences;
- Medicine and Pharmacology;
- Public Health and Healthcare;
- Others.
About MDPI Awards:
To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.
To explore more MDPI awards, please click here.
20 September 2024
Journal of Personalized Medicine | Most Viewed Papers in 2022–2023 in the Section “Disease Biomarker”

We are pleased to invite you to read the most viewed papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Disease Biomarker”. The list of papers is as follows.
1. “BMI at Discharge from Treatment Predicts Relapse in Anorexia Nervosa: A Systematic Scoping Review”
by Stein Frostad, Natalia Rozakou-Soumalia, Ştefana Dârvariu, Bahareh Foruzesh, Helia Azkia, Malina Ploug Larsen, Ehsan Rowshandel and Jan Magnus Sjögren
J. Pers. Med. 2022, 12(5), 836; https://doi.org/10.3390/jpm12050836
Available online: https://www.mdpi.com/2075-4426/12/5/836
Cited by 17+ | Viewed by 5920+
2. “Skin Cancer Research Goes Digital: Looking for Biomarkers within the Droplets”
by Elena-Georgiana Dobre, Carolina Constantin and Monica Neagu
J. Pers. Med. 2022, 12(7), 1136; https://doi.org/10.3390/jpm12071136
Available online: https://www.mdpi.com/2075-4426/12/7/1136
Cited by 7+ | Viewed by 4590+
3. “Langerhans Cells—Revising Their Role in Skin Pathologies”
by Monica Neagu, Carolina Constantin, Gheorghita Jugulete, Victor Cauni, Sandrine Dubrac, Attila Gábor Szöllősi and Sabina Zurac
J. Pers. Med. 2022, 12(12), 2072; https://doi.org/10.3390/jpm12122072
Available online: https://www.mdpi.com/2075-4426/12/12/2072
Cited by 5+ | Viewed by 3780+
4. “Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy”
by Riccardo Di Santo, Maria Vaccaro, Sabrina Romanò, Flavio Di Giacinto, Massimiliano Papi, Gian Ludovico Rapaccini, Marco De Spirito, Luca Miele, Umberto Basile and Gabriele Ciasca
J. Pers. Med. 2022, 12(6), 949; https://doi.org/10.3390/jpm12060949
Available online: https://www.mdpi.com/2075-4426/12/6/949
Cited by 20+ | Viewed by 3590+
5. “Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases”
by Alana Aragón-Herrera, Sandra Feijóo-Bandín, Laura Anido-Varela, Sandra Moraña-Fernández, Esther Roselló-Lletí, Manuel Portolés, Estefanía Tarazón, Oreste Gualillo, José Ramón González-Juanatey and Francisca Lago
J. Pers. Med. 2022, 12(7), 1021; https://doi.org/10.3390/jpm12071021
Available online: https://www.mdpi.com/2075-4426/12/7/1021
Cited by 10+ | Viewed by 3340+
6. “Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods”
by Francesca Maria Porta, Elham Sajjadi, Konstantinos Venetis, Chiara Frascarelli, Giulia Cursano, Elena Guerini-Rocco, Nicola Fusco and Mariia Ivanova
J. Pers. Med. 2023, 13(7), 1176; https://doi.org/10.3390/jpm13071176
Available online: https://www.mdpi.com/2075-4426/13/7/1176
Cited by 9+ | Viewed by 3180+
7. “Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder”
by Anton Shkundin and Angelos Halaris
J. Pers. Med. 2023, 13(9), 1395; https://doi.org/10.3390/jpm13091395
Available online: https://www.mdpi.com/2075-4426/13/9/1395
Cited by 10+ | Viewed by 2860+
8. “Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC)”
by Roberta Modica, Roberto Minotta, Alessia Liccardi, Giuseppe Cannavale, Elio Benevento and Annamaria Colao
J. Pers. Med. 2023, 13(6), 953; https://doi.org/10.3390/jpm13060953
Available online: https://www.mdpi.com/2075-4426/13/6/953
Cited by 14+ | Viewed by 2280+
9. “PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells”
by Bogdan Marian Caraban, Elena Matei, Georgeta Camelia Cozaru, Mariana Aşchie, Mariana Deacu, Manuela Enciu, Gabriela Izabela Bălţătescu, Anca Chisoi, Nicolae Dobrin, Lucian Petcu et al.
J. Pers. Med. 2023, 13(2), 221; https://doi.org/10.3390/jpm13020221
Available online: https://www.mdpi.com/2075-4426/13/2/221
Cited by 8+ | Viewed by 2240+
10. “Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure”
by Silvia Spoto, Josepmaria Argemi, Roberta Di Costanzo, Juan Josè Gavira Gomez, Nahikari Salterain Gonzales, Stefania Basili, Roberto Cangemi, Antonio Abbate, Luciana Locorriere, Francesco Masini et al.
J. Pers. Med. 2023, 13(7), 1155; https://doi.org/10.3390/jpm13071155
Available online: https://www.mdpi.com/2075-4426/13/7/1155
Cited by 6+ | Viewed by 1810+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
20 September 2024
Journal of Personalized Medicine | Highly Cited Papers in 2022–2023 in the Section “Methodology, Drug and Device Discovery”

We are pleased to invite you to read the highly cited papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Methodology, Drug and Device Discovery”. The list of papers is as follows.
1. “Artificial Intelligence-Driven Prediction Modeling and Decision Making in Spine Surgery Using Hybrid Machine Learning Models”
by Babak Saravi, Frank Hassel, Sara Ülkümen, Alisia Zink, Veronika Shavlokhova, Sebastien Couillard-Despres, Martin Boeker, Peter Obid and Gernot Michael Lang
J. Pers. Med. 2022, 12(4), 509; https://doi.org/10.3390/jpm12040509
Available online: https://www.mdpi.com/2075-4426/12/4/509
Cited by 62+ | Viewed by 8300+
2. “Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems”
by Stefano Marletta, Nicola Fusco, Enrico Munari, Claudio Luchini, Alessia Cimadamore, Matteo Brunelli, Giulia Querzoli, Maurizio Martini, Elena Vigliar, Romano Colombari et al.
J. Pers. Med. 2022, 12(7), 1073; https://doi.org/10.3390/jpm12071073
Available online: https://www.mdpi.com/2075-4426/12/7/1073
Cited by 46+ | Viewed by 6300+
3. “Predicting the Onset of Diabetes with Machine Learning Methods”
by Chun-Yang Chou, Ding-Yang Hsu and Chun-Hung Chou
J. Pers. Med. 2023, 13(3), 406; https://doi.org/10.3390/jpm13030406
Available online: https://www.mdpi.com/2075-4426/13/3/406
Cited by 37+ | Viewed by 6090+
4. “Pathophysiology, Classification and Comorbidities after Traumatic Spinal Cord Injury”
by James Guest, Nilanjana Datta, George Jimsheleishvili and David R. Gater
J. Pers. Med. 2022, 12(7), 1126; https://doi.org/10.3390/jpm12071126
Available online: https://www.mdpi.com/2075-4426/12/7/1126
Cited by 34+ | Viewed by 7200+
5. “CRIDECO Anticholinergic Load Scale: An Updated Anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish Individuals with Subjective Memory Complaints”
by Hernán Ramos, Lucrecia Moreno, Jordi Pérez-Tur, Consuelo Cháfer-Pericás, Gemma García-Lluch and Juan Pardo
J. Pers. Med. 2022, 12(2), 207; https://doi.org/10.3390/jpm12020207
Available online: https://www.mdpi.com/2075-4426/12/2/207
Cited by 33+ | Viewed by 8680+
6. “The Contribution of “Individual Participant Data” Meta-Analyses of Psychotherapies for Depression to the Development of Personalized Treatments: A Systematic Review”
by Pim Cuijpers, Marketa Ciharova, Soledad Quero, Clara Miguel, Ellen Driessen, Mathias Harrer, Marianna Purgato, David Ebert and Eirini Karyotaki
J. Pers. Med. 2022, 12(1), 93; https://doi.org/10.3390/jpm12010093
Available online: https://www.mdpi.com/2075-4426/12/1/93
Cited by 31+ | Viewed by 4650+
7. “Potential and Pitfalls of Mobile Mental Health Apps in Traditional Treatment: An Umbrella Review”
by Jerica Koh, Germaine Y. Q. Tng and Andree Hartanto
J. Pers. Med. 2022, 12(9), 1376; https://doi.org/10.3390/jpm12091376
Available online: https://www.mdpi.com/2075-4426/12/9/1376
Cited by 30+ | Viewed by 7240+
8. “Sex-Related Differences in Pharmacological Response to CNS Drugs: A Narrative Review”
by Mirabela Romanescu, Valentina Buda, Adelina Lombrea, Minodora Andor, Ionut Ledeti, Maria Suciu, Corina Danciu, Cristina Adriana Dehelean and Liana Dehelean
J. Pers. Med. 2022, 12(6), 907; https://doi.org/10.3390/jpm12060907
Available online: https://www.mdpi.com/2075-4426/12/6/907
Cited by 24+ | Viewed by 5680+
9. “FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint”
by Filippo Cappello, Valentina Angerilli, Giada Munari, Carlotta Ceccon, Marianna Sabbadin, Fabio Pagni, Nicola Fusco, Umberto Malapelle and Matteo Fassan
J. Pers. Med. 2022, 12(5), 750; https://doi.org/10.3390/jpm12050750
Available online: https://www.mdpi.com/2075-4426/12/5/750
Cited by 19+ | Viewed by 5380+
10. “Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making”
by Sebastian Griewing, Niklas Gremke, Uwe Wagner, Michael Lingenfelder, Sebastian Kuhn and Jelena Boekhoff
J. Pers. Med. 2023, 13(10), 1502; https://doi.org/10.3390/jpm13101502
Available online: https://www.mdpi.com/2075-4426/13/10/1502
Cited by 16+ | Viewed by 2360+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
11 September 2024
MDPI’s 2023 Best PhD Thesis Awards—Winners Announced

MDPI’s Best PhD Thesis Awards are granted to promising young scholars whose PhD theses are deemed exceptional within their respective research fields. These awards aim to encourage young scholars to continue their outstanding accomplishments and further contribute to their field.
We extend our heartfelt congratulations to the 54 winners of the 2023 Best PhD Thesis Awards and wish them success with their future research endeavors.
MDPI will continue to provide support and recognition to the academic community. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:
About MDPI Awards:
To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.
To explore more MDPI awards, please click here.
10 September 2024
Meet Us at the GSA 2024 Annual Scientific Meeting (GSA 2024), 13–16 November 2024, Seattle, USA

MDPI will be attending the GSA 2024 Annual Scientific Meeting (GSA 2024), which will be held from 13 to 16 of November 2024, in Seattle, USA.
The Gerontological Society of America (GSA) Annual Scientific Meeting draws professionals in the field of aging on a global scale, representing specialties including geriatrics, biological sciences, nursing, nutrition, medicine, social work, economics, policy, and psychology. The GSA is the largest and most established international, interdisciplinary scientific organization devoted to the advancement of gerontological research.
GSA 2024 offers numerous opportunities for career development and networking. Nearly 4,000 researchers, clinicians, educators, and other professionals will gather in Seattle to learn about and discuss the latest trends, research, and key issues in aging.
The following MDPI journals will be represented at the conference:
- Healthcare;
- Geriatrics;
- Nursing Report;
- Epidemiologia;
- Journal of Clinical Medicine (JCM);
- International Journal of Environmental Research and Public Health (IJERPH);
- European Journal of Investigation in Health, Psychology and Education (EJIHPE);
- Journal of Personalized Medicine (JPM);
- Nutrients;
- Journal of Ageing and Longevity (JAL);
- International Journal of Molecular Sciences (IJMS);
- Societies;
- Behavioral Sciences.
If you are planning to attend the conference, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries you may have. For more information about the conference, please visit the official website at https://www.gsa2024.org/.
3 September 2024
MDPI INSIGHTS: The CEO's Letter #15 - CHORUS, Best Paper Award, August Events

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
I am pleased to share that MDPI is now an Affiliate Member of CHORUS, a not-for-profit organization dedicated to ensuring public access to articles reporting on U.S. government-funded research. This partnership highlights our long-standing commitment to advancing Open Access (OA) publishing and meeting funders’ open research requirements.
Read the full announcement here.
With the White House Office of Science and Technology Policy (OSTP) 2022 memorandum calling for immediate public access to all federally funded research by 2026, this partnership positions MDPI to further support academic institutions in adhering to national mandates while providing authors with fully compliant (CC-BY) OA journals.
The CHORUS platform went live in July 2014 and includes NASA, the U.S. Department of Energy, the U.S. Department of Defense, the U.S. Geological Survey, and the National Science Foundation.
“This partnership positions MDPI to further support academic institutions in adhering to national mandates”
Joining CHORUS perfectly aligns our mission as the leading OA publisher, which is to drive transparency and innovation in scholarly publishing, with that of CHORUS itself, which is to advance Open Access research. It will also support MDPI publications from organizations such as NASA, with 1,200 research papers published by NASA-affiliated authors as at 31 August 2024.
Impactful Research
MDPI’s Best Paper Awards—Award-Winning Papers in 2023 Announced
MDPI is committed to supporting and recognizing the academic community and is proud to announce the recipients of the 2023 Best Paper Awards, which recognize high-quality papers of significant scientific merit and impact. Each year, the editors of our journals carefully select papers that showcase outstanding scientific achievement.
This year, 115 Best Paper Awards were presented, chosen from 346 exceptional papers in a highly competitive selection process. Congratulations to the authors for their remarkable contributions!
To learn more about all the awardees and their research projects, visit the following pages:
- Biology and Life Sciences
- Business and Economics
- Chemistry and Materials Sciences
- Computer Sciences and Mathematics
- Engineering
- Environmental and Earth Sciences
- Medicine and Pharmacology
- Public Health and Healthcare
- Social Sciences, Arts and Humanities
- Physical Sciences
About MDPI Awards
MDPI regularly offers various awards to recognize researchers, particularly young scientists, and to promote communication within the scientific community. These awards exist to inspire and acknowledge talented scientists who have made significant contributions to advancing their fields.
To find out more MDPI awards, please click here.
“Our awards exist to inspire and acknowledge talented scientists”
Inside MDPI
MDPI AI Team Presented at EuroSciPy 2024 in Poland
As part of the CEO Letter, I hold dear this ‘Inside MDPI’ section, where I have an opportunity to highlight various projects, teams and updates within our organization. As such, I’m happy to showcase the following presentations from members of MDPI’s Artificial Intelligence (AI) team, which were recently presented at the EuroSciPy 2024 (16th European Conference on Python in Science). This conference took place in Szczecin, Poland from 26–30 August.
“This event was a great opportunity to reinforce our commitment to innovation and excellence in publishing”
MDPI colleagues Frank Sauerburger (AI Tech Leader) and Daniele Raimondi (Senior Data Scientist) both presented at the conference. Frank discussed MDPI’s AI infrastructure, while Daniele showcased a new methodological approach we have been developing to track the journey of rejected academic manuscripts. This approach combines AI, data science and analytics to improve the identification of manuscripts and authors, enhancing our understanding of publishing dynamics.
This event was a great opportunity to reinforce our commitment to innovation and excellence in publishing. It also allowed us to contribute to the academic discussion on integrating AI and data science into scholarly communication.
From data analysis in Jupyter Notebooks to production applications: AI infrastructure at reasonable scale – Frank Sauerburger
Frank’s presentation on MDPI’s AI infrastructure provided a chance to showcase the advanced technological frameworks that power our operations. Given the technical and academic focus of EuroSciPy, this talk demonstrated how MDPI’s AI capabilities are not only cutting-edge but also central to driving efficiency and innovation in scholarly publishing. Engaging with the EuroSciPy community helps position MDPI as a leader in applying AI within the publishing industry, fostering potential collaborations and attracting interest from top researchers.
A Qdrant and Specter2 framework for tracking resubmissions of rejected manuscripts in academia – Daniele Raimondi
Daniele’s talk on the novel methodological approach that combines AI, Data Science, and Analytics was crucial in highlighting how MDPI is advancing the precision and effectiveness of manuscript and author identification. This approach is pivotal in enhancing our understanding of publishing dynamics and ensuring the quality and integrity of the academic content we manage. By presenting at EuroSciPy, we had the opportunity to engage with an audience deeply involved in scientific computing, gaining feedback and insights that could further refine our methodologies.
Thank you, Frank and Daniele, for representing MDPI so well!
I will share more about MDPI’s AI team and projects in upcoming CEO Letters, as we have a well-rounded AI and Data Team working on an exciting suite of AI products for MDPI and the scholarly community at large.
Coming Together for Science
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
I am pleased to share the success of our MDPI conference The 1st International Conference on Artificial Intelligence (AI) Sensors and the 10th International Symposium on Sensor Science in Singapore this past 1–4 August.
With nearly 400 attendees, the event brought together researchers and industry experts from China, Singapore, Japan, Korea, Taiwan, India and other countries to share their findings on the latest developments in sensors, sensing technology, artificial intelligence for sensing applications and AI-enhanced sensing systems.
We accepted a total of 355 abstracts, featuring 772 authors from 28 countries. Over the course of the four-day event, 66 posters were displayed and 296 talks were delivered, including 4 plenary talks, 46 keynote speeches, 122 invited talks, and 124 selected oral presentations. View the event gallery here.
I am pleased to announce the winners of the four awards, including Best Presentation and Best Poster, recognizing the contributions of our participants during the conference.
Looking ahead, the 2nd International Conference on AI Sensors and Transducers is scheduled to take place from 29 July to 5 August, 2025, in Bangkok, Thailand.
Thank you to our Conference team, including Ionut Spatar, Teodora Nicoleta Cremene, Ang Kai Lin, Benjamin Tay, Leong Jin Yue Esther, Wong Jolin, Judith Wu, Alethea Liu and Flora Li, who were involved in making this event a success. A big thank-you also goes to our local MDPI colleagues for their support: Yu Nwe Soe, Hen Chu Yang, Kwah Zhi En Watcharapong, Zephan Yang, Daphne Neo, Huimin Cheng, Nathan Li and Ting Yin.
Upcoming In-Person Event
25–27 September, 2024
The 5th International Conference on Materials: Advances in Material Innovation
Location: Basel, Switzerland
ICM 2024 will unite experts to share insights on recent advancements in Materials Characterization, Processing and Manufacturing.
7–9 October, 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland
ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.
Find more upcoming MDPI events here.
Closing Thoughts
The 2nd Sustainable Publishing Forum
In 2022, the International Association of Scientific, Technical and Medical Publishers (STM) outlined three goals to reflect the academic community’s shared aspirations: promoting Open Science, maintaining research integrity and fulfilling social responsibility. Open Science has evolved from the Open Access movement of the early 2000s to become a preferred model in academic publishing. Publishers and academic journals play a crucial role in ensuring research integrity, with efforts to prevent misconduct markedly on the increase now.
As the world faces sustainability challenges, the academic publishing industry is increasingly committed to contributing the achievement of the United Nations Sustainable Development Goals (SDGs). Many publishers are implementing strategies to support these objectives, including ours, which you can view here.
The 2nd MDPI Sustainable Publishing Forum provided a platform for global editors and publishers to discuss these themes, aiming to strengthen collaboration and advance the contributions that scientific publishing can make to academia and society.
“Open Science has evolved to become a preferred model in academic publishing”
The 2nd Sustainable Publishing Forum
We hosted MDPI’s 2nd Sustainable Publishing Forum in Beijing, China, on 15–16 August, attracting nearly 120 attendees from local and international publishers, university presses, scientific and technical journal associations, libraries and the Chinese Academy of Sciences. The event focused on promoting Open Science, maintaining research integrity, and fulfilling social responsibility.
This was an excellent opportunity for us to share more with conference attendees about the approach of our research integrity team. Our Head of Publishing, Peter Roth, also participated, speaking on how to identify and avoid predatory publishers and about the principles that underpin ethical academic publishing.
I extend my thanks to all of our conference speakers, including Hylke Koers (STM Solutions), who presented on STM Trends 2028 and shared insights on the STM Integrity Hub, of which MDPI is a member.
Chief Executive Officer
MDPI AG
23 August 2024
Journal of Personalized Medicine | Highly Cited Papers in 2022–2023 in the Section “Omics/Informatics”

We are pleased to invite you to read the highly cited papers from 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Omics/Informatics”. The list of papers is as follows:
1. “Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems”
by Roxana Filip, Roxana Gheorghita Puscaselu, Liliana Anchidin-Norocel, Mihai Dimian and Wesley K. Savage
J. Pers. Med. 2022, 12(8), 1295; https://doi.org/10.3390/jpm12081295
Available online: https://www.mdpi.com/2075-4426/12/8/1295
Cited by 135+ | Viewed by 11730+
2. “Computational Models for Clinical Applications in Personalized Medicine—Guidelines and Recommendations for Data Integration and Model Validation”
by Catherine Bjerre Collin, Tom Gebhardt, Martin Golebiewski, Tugce Karaderi, Maximilian Hillemanns, Faiz Muhammad Khan, Ali Salehzadeh-Yazdi, Marc Kirschner, Sylvia Krobitsch, EU-STANDS4PM consortium et al.
J. Pers. Med. 2022, 12(2), 166; https://doi.org/10.3390/jpm12020166
Available online: https://www.mdpi.com/2075-4426/12/2/166
Cited by 30+ | Viewed by 10270+
3. “Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases”
by Giulia Gentile, Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Francesca Luisa Conforti and Sebastiano Cavallaro
J. Pers. Med. 2022, 12(5), 770; https://doi.org/10.3390/jpm12050770
Available online: https://www.mdpi.com/2075-4426/12/5/770
Cited by 30+ | Viewed by 5820+
4. “The Evolution of a Large Biobank at Mass General Brigham”
by Natalie T. Boutin, Samantha B. Schecter, Emma F. Perez, Natasha S. Tchamitchian, Xander R. Cerretani, Vivian S. Gainer, Matthew S. Lebo, Lisa M. Mahanta, Elizabeth W. Karlson and Jordan W. Smoller
J. Pers. Med. 2022, 12(8), 1323; https://doi.org/10.3390/jpm12081323
Available online: https://www.mdpi.com/2075-4426/12/8/1323
Cited by 20+ | Viewed by 2410+
5. “Image Analysis in Digital Pathology Utilizing Machine Learning and Deep Neural Networks”
by Paris Amerikanos and Ilias Maglogiannis
J. Pers. Med. 2022, 12(9), 1444; https://doi.org/10.3390/jpm12091444
Available online: https://www.mdpi.com/2075-4426/12/9/1444
Cited by 15+ | Viewed by 3130+
6. “Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?”
by Claire Deligne, Sylvaine You and Roberto Mallone
J. Pers. Med. 2022, 12(4), 542; https://doi.org/10.3390/jpm12040542
Available online: https://www.mdpi.com/2075-4426/12/4/542
Cited by 10+ | Viewed by 5350+
7. “Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives”
by Xandra García-González, Esther Cubo, Lucía Simón-Vicente, Natividad Mariscal, Raquel Alcaraz, Laura Aguado, Jéssica Rivadeneyra-Posadas, Antonio Sanz-Solas and Miriam Saiz-Rodríguez
J. Pers. Med. 2023, 13(3), 385; https://doi.org/10.3390/jpm13030385
Available online: https://www.mdpi.com/2075-4426/13/3/385
Cited by 9+ | Viewed by 3740+
8. “Metabolic Profiling in Rheumatoid Arthritis, Psoriatic Arthritis, and Psoriasis: Elucidating Pathogenesis, Improving Diagnosis, and Monitoring Disease Activity”
by Erika Dorochow, Michaela Köhm, Lisa Hahnefeld and Robert Gurke
J. Pers. Med. 2022, 12(6), 924; https://doi.org/10.3390/jpm12060924
Available online: https://www.mdpi.com/2075-4426/12/6/924
Cited by 9+ | Viewed by 3540+
9. “Probiotics and Probiotic-like Agents against Chemotherapy-Induced Intestinal Mucositis: A Narrative Review”
by Laura López-Gómez, Alexandra Alcorta and Raquel Abalo
J. Pers. Med. 2023, 13(10), 1487; https://doi.org/10.3390/jpm13101487
Available online: https://www.mdpi.com/2075-4426/13/10/1487
Cited by 7+ | Viewed by 2870+
10. “Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers”
by Miriam Saiz-Rodríguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina Mejía-Abril et al.
J. Pers. Med. 2023, 13(3), 489; https://doi.org/10.3390/jpm13030489
Available online: https://www.mdpi.com/2075-4426/13/3/489
Cited by 7+ | Viewed by 2077+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
23 August 2024
Journal of Personalized Medicine | Highly Cited Papers in 2022–2023 in the Section “Mechanisms of Diseases”

We are pleased to invite you to read the highly cited papers from 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Mechanisms of Diseases”. The list of papers is as follows:
1. “Emerging Biomarkers for Early Detection of Chronic Kidney Disease”
by Maja Mizdrak, Marko Kumrić, Tina Tičinović Kurir and Joško Božić
J. Pers. Med. 2022, 12(4), 548; https://doi.org/10.3390/jpm12040548
Available online: https://www.mdpi.com/2075-4426/12/4/548
Cited by 40+ | Viewed by 8990+
2. “Multi-Omics Profiling Approach to Asthma: An Evolving Paradigm”
by Yadu Gautam, Elisabet Johansson and Tesfaye B. Mersha
J. Pers. Med. 2022, 12(1), 66; https://doi.org/10.3390/jpm12010066
Available online: https://www.mdpi.com/2075-4426/12/1/66
Cited by 30+ | Viewed by 5470+
3. “Endotypes of Prematurity and Phenotypes of Bronchopulmonary Dysplasia: Toward Personalized Neonatology”
by Maria Pierro, Karen Van Mechelen, Elke van Westering-Kroon, Eduardo Villamor-Martínez and Eduardo Villamor
J. Pers. Med. 2022, 12(5), 687; https://doi.org/10.3390/jpm12050687
Available online: https://www.mdpi.com/2075-4426/12/5/687
Cited by 20+ | Viewed by 7800+
4. “Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges”
by Francisco Silva, Tania Pereira, Inês Neves, Joana Morgado, Cláudia Freitas, Mafalda Malafaia, Joana Sousa, João Fonseca, Eduardo Negrão, Beatriz Flor de Lima et al.
J. Pers. Med. 2022, 12(3), 480; https://doi.org/10.3390/jpm12030480
Available online: https://www.mdpi.com/2075-4426/12/3/480
Cited by 20+ | Viewed by 5110+
5. “The Paris System for Reporting Urinary Cytology: A Meta-Analysis”
by Ilias P. Nikas, Svenja Seide, Tanja Proctor, Zoi Kleinaki, Maria Kleinaki and Jordan P. Reynolds
J. Pers. Med. 2022, 12(2), 170; https://doi.org/10.3390/jpm12020170
Available online: https://www.mdpi.com/2075-4426/12/2/170
Cited by 17+ | Viewed by 9560+
6. “Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches”
by Giacomo Miserocchi, Chiara Spadazzi, Sebastiano Calpona, Francesco De Rosa, Alice Usai, Alessandro De Vita, Chiara Liverani, Claudia Cocchi, Silvia Vanni, Chiara Calabrese et al.
J. Pers. Med. 2022, 12(6), 854; https://doi.org/10.3390/jpm12060854
Available online: https://www.mdpi.com/2075-4426/12/6/854
Cited by 16+ | Viewed by 3550+
7. “Effectiveness of Platelet-Rich Plasma Therapy in Androgenic Alopecia—A Meta-Analysis”
by Simona Roxana Georgescu, Andreea Amuzescu, Cristina Iulia Mitran, Madalina Irina Mitran, Clara Matei, Carolina Constantin, Mircea Tampa and Monica Neagu
J. Pers. Med. 2022, 12(3), 342; https://doi.org/10.3390/jpm12030342
Available online: https://www.mdpi.com/2075-4426/12/3/342
Cited by 14+ | Viewed by 8770+
8. “Is Ozone a Valid Adjuvant Therapy for Periodontitis and Peri-Implantitis? A Systematic Review”
by Francesco D’Ambrosio, Mario Caggiano, Alfonso Acerra, Massimo Pisano and Francesco Giordano
J. Pers. Med. 2023, 13(4), 646; https://doi.org/10.3390/jpm13040646
Available online: https://www.mdpi.com/2075-4426/13/4/646
Cited by 13+ | Viewed by 2660+
9. “Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer”
by Miguel A. Ortega, Leonel Pekarek, Fátima Navarro, Oscar Fraile-Martínez, Cielo García-Montero, Miguel Ángel Álvarez-Mon, Raúl Diez-Pedrero, María del Carmen Boyano-Adánez, Luis G. Guijarro, Silvestra Barrena-Blázquez et al.
J. Pers. Med. 2023, 13(2), 167; https://doi.org/10.3390/jpm13020167
Available online: https://www.mdpi.com/2075-4426/13/2/167
Cited by 9+ | Viewed by 3010+
10. “Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury”
by Sergio Haro Girón, Jorge Monserrat Sanz, Miguel A. Ortega, Cielo Garcia-Montero, Oscar Fraile-Martínez, Ana M. Gómez-Lahoz, Diego Liviu Boaru, Diego de Leon-Oliva, Luis G. Guijarro, Mar Atienza-Perez et al.
J. Pers. Med. 2023, 13(4), 626; https://doi.org/10.3390/jpm13040626
Available online: https://www.mdpi.com/2075-4426/13/4/626
Cited by 9+ | Viewed by 2254+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
19 August 2024
MDPI’s 2023 Young Investigator Awards—Winners Announced

MDPI’s Young Investigator Awards recognize promising early career scientists, acknowledge their contributions, and foster collaboration within the scientific community. We are proud to announce the recipients for 2023, who were carefully selected by the journals’ esteemed Award Evaluation Committee.
We extend our heartfelt congratulations to the 79 winners of MDPI’s 2023 Young Investigator Awards for their excellent contributions in their research field. We look forward to seeing these rising stars continue to contribute to the advancement of science.
MDPI will continue to support and recognize the academic community. To explore details about the awardees by field, please visit the individual pages listed below:
Congratulations to all the winners for their exceptional contributions and dedication to advancing scientific research.
About MDPI Awards:
To support the academic community, particularly young researchers, and to enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help to elevate the profiles of talented individuals who have made outstanding achievements and are making significant contributions to advancements in their respective fields.
To find out more about MDPI awards, please click here.
7 August 2024
MDPI Insights: The CEO's Letter #14 - New Headquarters, Marketing, Poland

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Moves to New Headquarters in Basel, Switzerland
I am excited to share that MDPI has moved to a new state-of-the-art office space in Basel, Switzerland. This move consolidates our operations by bringing together our two previously separated Basel offices into one central location.
We are always growing our talent pool and encourage you to view our Careers Page for the positions available in Basel and across our offices.
New Address: Grosspeteranlage 5, CH-4052 Basel, Switzerland
Effective Date: 1 July 2024
This new chapter in our company’s journey is designed to continue our mission of positioning MDPI as a leader in Open Access (OA) publishing, highlighting our commitment to making scholarly research accessible to everyone.
Boasting modern amenities, improved meeting and event spaces designed to support our growing needs, the new location provides a more collaborative and efficient working environment for our employees. The location offers convenient accessibility to public transportation and is situated near the Basel SBB railway station, with a variety of nearby services and amenities.
In fact, I can see the trains right outside of my window as I write these lines!
This move marks an exciting milestone in MDPI’s development, and I am confident that the new headquarters will serve as an inspiring and productive space for everyone. We also very much look forward to welcoming visitors here. You can read more about MDPI's history here.
“This new chapter continues our mission of positioning MDPI as a leader in OA publishing”
For Those New to MDPI
A pioneer in scholarly, Open Access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to Open Science by making a greater proportion of the research conducted worldwide free and accessible to everyone. To date, over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6,000 professional, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes within its 440 fully Open Access titles. MDPI supports more than 800 academic institutions worldwide, helping them adhere to national mandates while facilitating authors’ publication in fully compliant (CC BY) Open Access journals.
Impactful Research
New and Emerging MDPI Journals Making an Immediate Impact
Unpacking some of the Impact Factor updates from the June CEO Letter, I wanted to dive a little deeper into the 137 MDPI journals which received Impact Factor for the first time.
Academic authors highly value efficient publishing processes, robust editorial support, and the opportunity to publish in high-impact journals. We are proud that our newly launched journals typically achieve coverage in the Emerging Sources Citation Index (ESCI) of the Web of Science within just a few years, with a median time of only three years from release to inclusion.
As part of our commitment to advancing academic research and providing high-quality OA publishing, we actively seek new research areas to expand our portfolio of journals. We have a proven track record of successfully establishing new journals.
Our dedicated teams excel in fostering dynamic editorial boards and working closely with Editors-in-Chief (EiC) to define the precise scope and focus of each new journal. Our expertise extends to collaborating with indexing services, ensuring that our journals comply with best practices and are indexed promptly in all relevant databases.
Emerging Titles Ranked for the First Time
Our commitment to excellence is reflected in the annual impact metrics released this past June. The latest edition of the Journal Citation Reports (JCR) showcases the integration of journals from the ESCI in the new unified category rankings, providing a simplified and more complete view of all journals within each subject category, including newly established titles.
Out of 137 new and developing MDPI journals ranked in the 2024 release, 79 are in the top half (Q1 or Q2) of their categories. Here is a breakdown of the number of MDPI’s ESCI-indexed journals by quartile in the JCR:
Quartile | No. of journals |
Q1 | 17 (12.4%) |
Q2 | 62 (45.3%) |
Q3 | 43 (31.4%) |
Q4 | 15 (10.9%) |
Not ranked (humanities-related journals) | 2 |
These rankings highlight our success in rapidly establishing high-impact new journals. Among those that made it directly into the top 25% of their category are the International Journal of Neonatal Screening, Journal of Xenobiotics, Polysaccharides, Smart Cities, and thirteen other journals.
You can browse MDPI journals by Indexing. Simply visit our Journals page and select from the list of Indexing bodies in the top left-hand corner.
Inside MDPI
MDPI Corporate Marketing Strategy and Team Meeting 2024
In July, I hosted the annual Corporate Marketing strategy and team-building activity with 15 of our team members.
The aim was to align the Corporate Marketing strategy with MDPI's goal of becoming the world's most trusted OA publisher. While we provide a high-level publishing experience for our authors, as seen from our surveys, we need to keep building on our transparent and open communication to foster trust within the scholarly community and continue enhancing our reputation.
The Corporate Marketing team plays an important role as the mouthpiece for all our major activities within MDPI, especially those that model what it means to be a trusted partner. The purpose of the strategy meeting was to develop a feeling of trust in one another and an understanding of how to inspire trust in the stakeholders with whom we interact.
“We need to keep building on our transparent and open communication to foster trust within the scholarly community”
We conducted a set of activities to facilitate that sense of mutual trust and trustworthiness. Examples of some activities we worked on during this strategy-building event include:
- Exploring what trust means
- ‘Letter to self’
- ‘The brand I most trust’
- Most Trusted Academic Publisher
- ‘The brand I would like MDPI to become’
- ‘The 2029 MDPI Annual Report’
- Voice of Customer and Share of Voice – survey/data update on MDPI Brand Experience and Brand Perception
- Integrate Trust-Based Objective into Marketing Plan
- ‘Becoming the MDPI experience’
- ‘Trusting the next steps’
While two days is not enough to finalize a marketing strategy, it is sufficient to get everyone who attended into the mindset of the direction in which we are working. From here, we will develop a program with next steps on main projects, update communications, and collaborate with team leads to incorporate this approach into our work going forward.
As a marketing team, we can communicate our messages, but trust has to be built at every touchpoint in the stakeholder journey. Just talking about it isn’t enough. We need to be about it. That’s a role each of us plays, from editorial to IT, from marketing to HR. We must build trust from the inside out. It starts with each manager and resonates out via every team member.
As a company, our goal is to give all stakeholders with whom we interact – whether internal or external – the experience of working with an organization it can trust.
Coming Together for Science
MDPI in Poland: Krakow Office
In July, I had the pleasure of visiting our Krakow office, following my recent trip to Warsaw to meet with the Polish Ministry of Science and Higher Education.
During these visits, I prioritized meeting with our Office Manager, Editorial Director, Group Leads, and members from various teams, including editorial, production, marketing, and journal relationship specialists, to understand their roles and current challenges. Instead of a formal presentation, I opted for an open discussion, sharing updates from headquarters to engage with colleagues in a more personal way.
Our Krakow office has many things to be proud of, including a large number of PhD colleagues (over a third of its staff holds a PhD degree). Krakow provides an opportunity for expanding beyond the 100 colleagues we currently have, by adding new hires in departments including editorial, production and marketing, among others.
About our Krakow office
- Opened in 2020
- 99 staff members as at 1 August 2024
- Main Departments include Editorial, Production, English Department, JRS, PR
Our Krakow office participates in international conferences, conducts author trainings and scholar visits, and engages in local market outreach. The office is also a member of the Polish Chamber of Commerce for High Technology (IZTECH) and is working on expanding its local engagement.
Krakow is the second-largest city in Poland, with a population of about 800,000. It also has a large student population of around 128,000, with seven universities. This means that roughly one in every eight residents is a student.
Poland and MDPI
Poland is a crucial market for MDPI. From 2020 to June 2024, Poland ranked 7th in submissions and 5th in publications for MDPI research articles. As at 31 July 2024, Poland ranks 7th in total MDPI publications, with approximately 70,000 research papers.
Between 2020 and June 2024, 61,500 authors from Poland published with MDPI. As at 30 June 2024, there are 1,205 active Editorial Board Members (EBMs) from Poland, with 661 EBMs (55% of the total) having an H-index over 25.
We also have four Editors-in-Chief (EiC) from Poland leading our journals: Coatings, Venereology, Advances in Respiratory Medicine, and Limnological Review, along with six Section EiC.
In 2023, we received approximately 21,000 submissions from Polish-affiliated authors, of which 12,032 were published.
“Poland is a crucial market for MDPI”
Meeting with Ministry of Education
On 22 July, we visited Warsaw to meet with the Polish Ministry of Science and Higher Education.
We were pleased to learn that they are strong supporters of the OA publishing model and value MDPI’s approach to the peer-review process, including our high ethical standards for quality control.
In 2023 Polish authors predominantly published their papers in OA, with MDPI holding the largest market share in OA publications within the country.
Our commitment to collaborating with Polish institutions is evident through our 33 Institutional Open Access Program (IOAP) agreements with prestigious institutions such as the University of Warsaw, the University of Wroclaw, the Jagiellonian University, and Gdańsk University of Technology. Through IOAP discounts, a healthy waiver rate, and our peer-review voucher system, we provide the Polish scholarly community with significant savings in OA publishing. The Minister greatly appreciated these efforts and our commitment to offsetting some of the APC costs.
We discussed industry concerns about the threat of papermills and presented the preventive measures MDPI has in place to mitigate this risk and uphold high ethical standards. We informed them of our commitment to combating papermills, including our involvement with United2Act and the STM Research Integrity Hub, as well as our efforts to expand our research integrity team and explore proactive measures.
Closing Thoughts
MDPI Thought Leadership Op-ed on Open Access is Now Live on Politico
I am pleased to share that our thought leadership Op-ed piece on Open Access (OA) is now live on Politico. This is a nice push for continued influence and support of OA among policymakers and industry leaders.
Why Politico?
Politico's reputation as a highly credible and influential news platform makes it an important venue to reach key opinion leaders (KOL) from academia, policymakers, and thought leaders from many industries. This visibility helps promote the OA philosophy.
Open Access: A Moral Imperative for Progress
In this piece, I discuss the necessity of making scientific research freely available to all. I argue that publicly funded research should be publicly accessible, highlighting how OA democratizes scientific knowledge, accelerates research availability, and fosters collaboration.
“Open Access is a fundamental right for all citizens”
Democratizing scientific communication
The impulse to democratize scientific communication is nothing new. OA may seem like a recent innovation, but its principles have historical roots traceable to Europe in the 15th century. Just as the printing revolution accelerated the dissemination of new ideas, OA publishing unlocks new scientific insights that would otherwise only be accessible to a few.
Benefits for scholars: amplifying impact through Open Access
Authors publishing in an OA journal can expect more citations of their work, increasing its potential impact. Research findings that are freely available are more likely to be cited than those hidden behind a paywall. Freedom of access greatly increases the potential audience for each paper, fostering a sense of community among researchers worldwide. Heightened visibility can attract prospective collaborators and employers for young scientists. At MDPI, we believe that all these factors can only accelerate the advance of science. Additionally, authors retain copyright in their work instead of signing it away, permitting broader dissemination under Creative Commons licenses and increasing its capacity for impact.
The moral imperative
OA is not just a matter of scientific policy; it is a fundamental right for all citizens and a prerequisite for a brighter, more informed future. Publicly funded research should be a top priority, and I am pleased to see policy moving in this direction. Our capacity to generate transformative scientific insights has to be democratized. The question today is no longer whether we can afford to embrace OA; rather, it is whether we can afford not to.
Chief Executive Officer
MDPI AG